A detailed history of Thomas White International LTD transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Thomas White International LTD holds 61,850 shares of RDY stock, worth $935,172. This represents 0.83% of its overall portfolio holdings.

Number of Shares
61,850
Previous 67,218 7.99%
Holding current value
$935,172
Previous $3.83 Million 2.01%
% of portfolio
0.83%
Previous 0.82%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$53.34 - $63.11 $286,329 - $338,774
-5,368 Reduced 7.99%
61,850 $3.9 Million
Q1 2023

May 15, 2023

SELL
$51.63 - $56.93 $137,439 - $151,547
-2,662 Reduced 3.81%
67,218 $3.83 Million
Q4 2022

Feb 14, 2023

SELL
$51.15 - $57.45 $558,455 - $627,239
-10,918 Reduced 13.51%
69,880 $3.62 Million
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $1.8 Million - $2.07 Million
36,090 Added 80.72%
80,798 $4.23 Million
Q2 2022

Aug 12, 2022

BUY
$49.62 - $58.13 $2.22 Million - $2.6 Million
44,708 New
44,708 $2.48 Million
Q1 2022

May 13, 2022

SELL
$48.27 - $65.25 $8,495 - $11,484
-176 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$60.19 - $75.29 $4.72 Million - $5.91 Million
-78,442 Reduced 99.78%
176 $11,000
Q2 2021

Aug 12, 2021

BUY
$62.12 - $74.2 $223,880 - $267,416
3,604 Added 4.8%
78,618 $5.78 Million
Q1 2021

May 12, 2021

BUY
$57.98 - $73.08 $355,069 - $447,541
6,124 Added 8.89%
75,014 $4.61 Million
Q4 2020

Feb 12, 2021

BUY
$62.61 - $71.29 $163,036 - $185,639
2,604 Added 3.93%
68,890 $4.91 Million
Q3 2020

Nov 13, 2020

BUY
$51.39 - $72.41 $976,923 - $1.38 Million
19,010 Added 40.21%
66,286 $4.61 Million
Q2 2020

Aug 12, 2020

BUY
$39.55 - $54.65 $1.87 Million - $2.58 Million
47,276 New
47,276 $2.51 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.51B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Thomas White International LTD Portfolio

Follow Thomas White International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas White International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Thomas White International LTD with notifications on news.